hims glp-1 california & Hers Is Selling Copycat Weight-Loss Drugs. Here's How Hims & Hers Health addresses

Does Semaglutide Improve Depressive Symptoms in Patients With Major Depressive Disorder and Overweight or Obesity (SEMAMOOD) ID NCT07136714

Pomegranate Sometimes added for an antioxidant/superfood angle, not central to weight-loss claims

How much will be the obesity GLP-1 market growth between 2025 and 2035

As the research grows, one thing is clear: GLP-1 medications are changing the way we think about chronic disease and metabolic health

Your body is adjusting to a fundamentally different pace of digestion, and that adjustment takes time

Tirzepatide is technically a dual GIP and GLP-1 receptor agonist, but many patients group it with GLP-1 weight-loss injections because it affects the GLP-1 pathway